1.Plasma G-CSF and GM-CSF Concentrations and Expression of their Receptors on the Granulocyte in Children with Leukocytosis.
Won Seok CHOI ; Kyung Hwan RYU ; You Jeong KIM ; So Young KIM ; Hyun Hee KIM ; Wonbae LEE
Journal of the Korean Pediatric Society 2003;46(3):271-276
PURPOSE: Granulocyte-colony stimulating factor(G-CSF) and granulocyte macrophage-colony stimulating factor(GM-CSF) are principal cytokines in granulopoiesis and their physiologic effects are mediated through binding to specific cell surface receptors. Although it is known that the level of serum G-CSF and GM-CSF, and presentation of the receptors are increased in infectious diseases, there have been no studies to find the correlation between the granulopoiesis and leukocytosis. This study was designed to measure G-CSF and GM-CSF in leukocytosis and in control and to demonstrate the possible pathogenesis of granulopoiesis in leukocytosis using quantitative analysis of G- CSF, GM-CSF and their CSFr. METHODS: The plasma levels of G-CSF, GM-CSF of 13 children without leukocytosis and 14 children with leukocytosis were measured. Counts of cell surface G-CSFr and GM-CSFr were measured by combining anti G-CSFr and anti GM-CSFr monoclonal antibodies to their respective receptors by using quantitative flow cytometric assay. RESULTS: There was no significant difference betweeen the plasma concentration of G-CSF and GM-CSF in acute leukocytosis and in the control group. However, levels of G-CSFr in acute leukocytosis decreased significantly compared to the control(P=0.012) and the levels of GM-CSFr in both groups revealed no significant difference. CONCLUSION: Increase in the number of leukocyte in leukocytosis was mediated by increasing the number of neutrophil, and increased plasma concentration of G-CSF may be the cause of neutrophilia. But GM-CSF did not have any influence on leukocytosis.
Antibodies, Monoclonal
;
Child*
;
Communicable Diseases
;
Cytokines
;
Granulocyte Colony-Stimulating Factor*
;
Granulocyte-Macrophage Colony-Stimulating Factor*
;
Granulocytes*
;
Humans
;
Leukocytes
;
Leukocytosis*
;
Neutrophils
;
Plasma*
;
Receptors, Cell Surface
;
Receptors, Granulocyte Colony-Stimulating Factor
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
2.Plasma G-CSF and GM-CSF Concentration and Amount of Their Receptors on the Granulocyte in Kawasaki Disease.
Young Kyoung YOO ; Gibum LEE ; Hyun Hee KIM ; Soo Young KIM ; You Jeong KIM ; Wonbae LEE
Journal of the Korean Pediatric Society 2003;46(4):376-381
PURPOSE: This study aimed to demonstrate the possible pathogenesis of granulopoiesis in patients of Kawasaki disease(KD) using quantitative analysis of G-CSF, GM-CSF and their CSFr. METHODS: The plasma levels of G-CSF, GM-CSF, G-CSFr and GM-CSFr were studied in 14 patients in the acute phase of KD; 13 children with normal peripheral white blood cell counts were used as the normal control group. The plasma concentration of G-CSF, GM-CSF were analyzed by ELISA. The G-CSFr and GM-CSFr on the peripheral granulocytes were analyzed by a quantitative flow cytometric assay and QuantiBRITE, and the quantitative changes of receptors which did not combine with G-CSF and GM-CSF were measured. RESULTS: The total number of leukocytes in KD was similar to normal control group, but the leukocytes increased according to the number of neutrophils. The plasma concentration of G-CSF were decreased similar to normal control group(P=0.133), but that of GM-CSF decreased more than the normal control group(P=0.227). The quantity of G-CSFr, GM-CSFr were revealed to be no less than the normal control(P=0.721, P=0.912). After incubation with excessive G-CSF, the expressed G-CSFr on the neutrophils were decreased in both groups(P=0.554). The quantities of expressions of GM- CSFr on the neutrophil after incubation with the excessive GM-CSF were always increased in both groups(P=0.255). The amount of GM-CSFr of neutrophils are in proportion to total white blood cells (r=0.788, P=0.035), but it wasn't in the case of KD(P=0.644). CONCLUSION: The leukocytosis in KD that mediated by increasing neutrophil was not correlated with the plasma concentrations of G-CSF and GM-CSF, and the amount of expression of G-CSFr and GM-CSFr on granulocyte. It is possible that the reduction of concentration of GM-CSF results by increasing the active GM-CSFr.
Child
;
Enzyme-Linked Immunosorbent Assay
;
Granulocyte Colony-Stimulating Factor*
;
Granulocyte-Macrophage Colony-Stimulating Factor*
;
Granulocytes*
;
Humans
;
Leukocyte Count
;
Leukocytes
;
Leukocytosis
;
Mucocutaneous Lymph Node Syndrome*
;
Neutrophils
;
Plasma*
;
Receptors, Granulocyte Colony-Stimulating Factor
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
3.Serum amyloid A inhibits dendritic cell differentiation by suppressing GM-CSF receptor expression and signaling.
Ji Cheol KIM ; Young Su JUNG ; Ha Young LEE ; Joon Seong PARK ; Yoe Sik BAE
Experimental & Molecular Medicine 2017;49(8):e369-
In this study, we report that an acute phase reactant, serum amyloid A (SAA), strongly inhibits dendritic cell differentiation induced by GM-CSF plus IL-4. SAA markedly decreased the expression of MHCII and CD11c. Moreover, SAA decreased cell surface GM-CSF receptor expression. SAA also decreased the expression of PU.1 and C/EBPα, which play roles in the expression of GM-CSF receptor. This inhibitory response by SAA is partly mediated by the well-known SAA receptors, Toll-like receptor 2 and formyl peptide receptor 2. Taken together, we suggest a novel insight into the inhibitory role of SAA in dendritic cell differentiation.
Dendritic Cells*
;
Granulocyte-Macrophage Colony-Stimulating Factor*
;
Interleukin-4
;
Receptors, Formyl Peptide
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor*
;
Serum Amyloid A Protein*
;
Toll-Like Receptors
4.Quantities of Receptor Molecules for Colony Stimulating Factors on Leukocytes in Measles.
You Jeong KIM ; So Young KIM ; Young Yoo KIM ; Jong Wan KIM ; Je Hoon LEE ; Kyung Ja HAN ; Won Bae LEE
Yonsei Medical Journal 2002;43(1):43-47
We analyzed the comparative amounts of granulocyte-colony stimulating factor (G-CSFr) and granulocyte macrophage CSF (GM-CSFr) receptors expressed on neutrophils and monocytes in measles patients to investigate the role of these CSFrs in the development of leukopenia including neutropenia and monocytopenia in measles. EDTA-anticoagulated peripheral blood of 19 measles patients, 10 children with other infections showing leukopenia and 16 children with normal complete blood cell counts (CBC)s were analyzed using flow cytometry and QuantiBRITE. The leukocyte (5260 +/- 2030/uL vs. 9900 + 2680/uL, p=0.000), neutrophil (2580 +/- 960/uL vs. 4250 +/- 2750/uL, p=0.024) and the lymphocyte counts of measles patients (1810 +/- 1430/uL vs. 4530 +/- 3450/uL, p= 0.006) were lower than in the normal controls. The neutrophils of measles patients expressed similar amounts of G- CSFr (1858 +/- 355) as normal children (1764 +/- 477, p= 0.564) and leukopenic patients (1773 +/- 673, p=0.713), but lower levels of GM-CSFr (535 +/- 118) than normal children (957 +/- 344, p=0.000) and leukopenic patients (832 +/- 294, p=0.002). The monocytes of measles patients expressed similar amounts of G-CSFr (916 +/- 336) and GM-CSFr (3718 +/- 906) as normal children (1013 +/- 391 and 4125 (2645, p > 0.05) but less than leukopenic patients (1454 +/- 398 and 5388 +/- 806, p > 0.05). The neutrophil and monocyte counts of measles patients did not correlate with the amount of G-CSFr or GM-CSFr expressed on neutrophils or monocytes (p > 0.05), but in the normal children, the monocyte count correlated with the levels of GM-CSFr on monocytes (r=0.951, p=0.049). In conclusion, neutropenia is one of the more important characteristics of measles patients, which could be due to the decreased GM-CSFr expression on neutrophils. However, the monocytopenia found in measles patients is not due to the decreased expression of CSFr on the monocytes.
Human
;
Leukocyte Count
;
Measles/*blood
;
Monocytes/*chemistry
;
Neutropenia/etiology
;
Neutrophils/*chemistry
;
Receptors, Granulocyte Colony-Stimulating Factor/*blood
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*blood
5.G-CSF and Its Receptor in Hematonosis.
Journal of Experimental Hematology 2015;23(3):871-877
The granulocyte colony-stimulating factor (G-CSF), now referred to as CSF3, is a very important cell growth factor that supports the proliferation, survival, and differentiation of neutrophilic progenitor cells, and also is a strong immune regulator of T cells and a promising therapeutic tool in acute graft versus host disease (GVHD). G-CSF acts by binding to its receptor G-CSFR (also called CSF3R), a member of the cytokine receptor type I superfamily, which after binding with G-CSF activates the canonical Janus kinase (Jak)/signal transducer, activator of transcription (STAT)and Ras/Raf/MAP kinase pathways. G-CSF has been applied to the clinic to treat congenital and acquired neutropenia before or during courses of intensive chemotherapy. It has also been applied to mobilize hematopoietic stem cells into the peripheral blood for Auto-or allogeneic transplantation, and the priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents in protocols aimed to induce their differentiation, accompanying growth arrest, and cell death. With the rapid development of molecular genetics and clinical research, CSF3R mutations have been implicated in the progression of severe congenital neutropenia (SCN) to leukemia. Recently, CSF3R mutations have been discovered frequently in chronic neutrophilic leukemia (CNL). Such findings might provide the theoretical basis for the targeted therapy. In this review, the clinical application of G-CSF receptor in hematonosis is briefhy summarized.
Graft vs Host Disease
;
Granulocyte Colony-Stimulating Factor
;
Hematopoiesis
;
Hematopoietic Stem Cells
;
Humans
;
Leukemia
;
Mutation
;
Neutropenia
;
congenital
;
Receptors, Granulocyte Colony-Stimulating Factor
;
Signal Transduction
;
Transplantation, Homologous
6.Effects of granulocyte-colony stimulating factor and the expression of its receptor on various malignant cells.
Hee Won MOON ; Tae Young KIM ; Bo Ra OH ; Sang Mee HWANG ; Jiseok KWON ; Ja Lok KU ; Dong Soon LEE
Korean Journal of Hematology 2012;47(3):219-224
BACKGROUND: Granulocyte-colony stimulating factor (G-CSF) is extensively used to improve neutrophil count during anti-cancer chemotherapy. We investigated the effects of G-CSF on several leukemic cell lines and screened for the expression of the G-CSF receptor (G-CSFR) in various malignant cells. METHODS: We examined the effects of the most commonly used commercial forms of G-CSF (glycosylated lenograstim and nonglycosylated filgrastim) on various leukemic cell lines by flow cytometry. Moreover, we screened for the expression of G-CSFR mRNA in 38 solid tumor cell lines by using real-time PCR. RESULTS: G-CSF stimulated proliferation (40-80% increase in proliferation in treated cells as compared to that in control cells) in 3 leukemic cell lines and induced differentiation of AML1/ETO+ leukemic cells. Among the 38 solid tumor cell lines, 5 cell lines (hepatoblastoma, 2 breast carcinoma, squamous cell carcinoma of the larynx, and melanoma cell lines) showed G-CSFR mRNA expression. CONCLUSION: The results of the present study show that therapeutic G-CSF might stimulate the proliferation and differentiation of malignant cells with G-CSFR expression, suggesting that prescreening for G-CSFR expression in primary tumor cells may be necessary before using G-CSF for treatment.
Breast
;
Carcinoma, Squamous Cell
;
Cell Line
;
Cell Line, Tumor
;
Flow Cytometry
;
Granulocyte Colony-Stimulating Factor
;
Larynx
;
Melanoma
;
Neutrophils
;
Receptors, Granulocyte Colony-Stimulating Factor
;
Recombinant Proteins
;
RNA, Messenger
7.Local Injection of Granulocyte-Colony Stimulating Factor Accelerates Wound Healing in a Rat Excisional Wound Model.
Guang Yin SHEN ; In Hwa PARK ; Yi Sun SONG ; Hyun Woo JOO ; Yonggu LEE ; Jeong Hun SHIN ; Kyung Soo KIM ; Hyuck KIM
Tissue Engineering and Regenerative Medicine 2016;13(3):297-303
A systemic treatment of granulocyte-colony stimulating factor (G-CSF) is known to improve healings of damaged tissues. However, recent studies suggested local actions of G-CSF on the healing processes of damaged tissues. We investigated the treatment effect of locally injected G-CSF and compared to that of systemically injected G-CSF in a rat model. A wound was created on the rat dorsum and treated either by local injection or by systemic injection of G-CSF. Wound healing rate, deposition of collagen, and gene expression were evaluated. G-CSF receptor (G-CSFR) protein was detected by Western blotting. The wound healing rate in the local injection group was significantly higher than that in the systemic injection group at days 9 and 15; it was also significantly higher than that in the control group at days 3, 9, and 15. The expression of G-CSFR protein in wound tissues was higher than in normal skin tissues. The local injection of G-CSF is more effective than systemic injection of G-CSF in promoting wound healing, which may implicate the local action of G-CSF treatment in wound healing processes.
Animals
;
Blotting, Western
;
Collagen
;
Gene Expression
;
Granulocyte Colony-Stimulating Factor
;
Models, Animal
;
Rats*
;
Receptors, Granulocyte Colony-Stimulating Factor
;
Skin
;
Wound Healing*
;
Wounds and Injuries*
8.A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry.
Satoru JOSHITA ; Koh NAKAZAWA ; Shoichiro KOIKE ; Atsushi KAMIJO ; Kiyoshi MATSUBAYASHI ; Hideharu MIYABAYASHI ; Kiyoshi FURUTA ; Kiyoshi KITANO ; Kaname YOSHIZAWA ; Eiji TANAKA
Journal of Korean Medical Science 2010;25(3):476-480
Granulocyte-colony stimulating factor (G-CSF) is a naturally occurring glycoprotein that stimulates the proliferation and maturation of precursor cells in the bone marrow into fully differentiated neutrophils. Several reports of G-CSF-producing malignant tumors have been published, but scarcely any in the hepatobiliary system, such as in hepatocellular carcinoma (HCC). Here, we encountered a 69-yr-old man with a hepatic tumor who had received right hepatic resection. He showed leukocytosis of 25,450/microL along with elevated serum G-CSF. Histological examination of surgical samples demonstrated immunohistochemical staining for G-CSF, but not for G-CSF receptor. The patient survived without recurrence for four years, but ultimately passed away with multiple bone metastases. In light of the above, clinicians may consider G-CSF-producing HCC when encountering patients with leukocytosis and a hepatic tumor. More cases are needed to clarify the clinical picture of G-CSF-producing HCC.
Aged
;
Bone Neoplasms/secondary
;
Carcinoma, Hepatocellular/*metabolism/pathology
;
Fatal Outcome
;
Granulocyte Colony-Stimulating Factor/*metabolism
;
Humans
;
Liver Neoplasms/*metabolism/pathology
;
Male
;
Receptors, Granulocyte Colony-Stimulating Factor/metabolism
9.Inhibition of Fungi-Induced Nasal Polyp Epithelial Cells Activation by Corticosteroids.
Journal of Rhinology 2006;13(1):32-36
BACKGROUND AND OBJECTIVES: Airway epithelial cells contribute to the pathogenesis of air disease by their interaction with inhalant pathogenic extracts. Airborne fungi interact with nasal epithelial cell and enhance the production of inflammatory cytokines. Glucocorticosteroids (GCs) have been used therapeutically for nasal polyps and allergic disease with potent anti-inflammatory effects. The purpose of this study was to investigate the inhibitory effect of GCs on fungi induced nasal epithelial cell activation. MATERIALS AND METHODS: The epithelial cells of nasal polyps were obtained from patients and stimulated with Alternaria. To evaluate the anti-inflammatory effects of GCs, Alternaria was pretreated with GCs (triamcinolone, dexamethasone, and budesonide) and cultured with epithelial cells. Interleukin-8 (IL-8) and granulocyte-macrophage colony stimulating factor (GM-CSF) were measured to determine the activation of epithelial cells. Reverse transcriptase-polymerase chain reaction (RT-PCR) test for protease-activated receptors (PARs) mRNA expression in nasal epithelial cells were performed. RESULTS: Alternaria enhanced the production of IL-8 and GM-CSF from nasal epithelial cells. GCs inhibited the activation of nasal epithelial cells, but the PAR2 and PAR3 mRNA expression were not suppressed by GCs. CONCLUSION: These data suggest that GCs inhibit the production of chemical mediators by Alternaria, but anti-inflammatory effect of GCs are not associated with PARs.
Adrenal Cortex Hormones*
;
Alternaria
;
Colony-Stimulating Factors
;
Cytokines
;
Dexamethasone
;
Epithelial Cells*
;
Fungi
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
Humans
;
Interleukin-8
;
Nasal Polyps*
;
Receptors, Proteinase-Activated
;
RNA, Messenger
10.Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes.
Kyo Young LEE ; Byung Gyu SUH ; Jong Wan KIM ; Won Bae LEE ; So Young KIM ; Young Yoo KIM ; Je Hoon LEE ; Ji Hyang LIM ; Myung Shin LIM ; Chang Suk KANG ; Kyung Ja HAN
Experimental & Molecular Medicine 2000;32(4):210-215
Administration of G-CSF may not always respond in rise of neutrophil counts in different patient population. In order to understand a possible inter-relationship between the G-CSF and GM-CSF induced leukocyte responses and expression levels of receptors for G-CSF (G-CSFr) and GM-CSF (GM-CSFr), the levels of each receptor and CSF were measured in patients with basophilia (8), eosinophilia (14) and bacterial infection showing neutrophilia (12) in comparison with normal healthy adults (12) and children (14). G-CSFr was expressed in neutrophils in the largest amount followed by monocytes, but GM-CSFr was expressed more in monocytes than neutrophils. Lymphocytes and basophils did not express G-CSFr or GM-CSFr. The amount of GM-CSFr in neutrophils was present less in patients with infection than normal control (P = 0.031). The neutrophils expressed more G-CSFr than GM-CSFr. The quantity of G-CSFr in eosinophil showed marked interval change, higher in acute stage. The plasma concentrations of G-CSF in patients with infection were much higher than normal adults or children (117.95 +/- 181.16 pg/ml, P < 0.05). Binding assay with excess amount of CSFs could discriminate the patient who did not show any response to G-CSF or GM-CSF administration. After incubation with excess CSFs, more receptors were blocked in children than in adults (G-CSF P = 0.024, GM-CSF P = 0.006). These results indicate that the amount of CSFr in leukocyte varies in different types of leukocyte, and changes according to the patients' condition even in the same type of leukocyte, and the CSFrs of children bind to CSFs more than those of adults.
Adult
;
*Bacterial Infections
;
Basophils/chemistry
;
Breast Neoplasms
;
Child
;
Colony-Stimulating Factors/*blood
;
Eosinophilia
;
Human
;
Leukemia, Myeloid, Chronic
;
*Leukocyte Disorders
;
Monocytes/chemistry
;
*Neoplasms
;
Neutrophils/chemistry
;
Receptors, Colony-Stimulating Factor/*analysis
;
Receptors, Granulocyte Colony-Stimulating Factor/analysis
;
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/analysis